Ibex Investors LLC Takes Position in Danimer Scientific, Inc. (NYSE:DNMR)

Ibex Investors LLC bought a new stake in Danimer Scientific, Inc. (NYSE:DNMR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 27,000 shares of the company’s stock, valued at approximately $676,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DNMR. Parcion Private Wealth LLC raised its position in shares of Danimer Scientific by 16.4% in the second quarter. Parcion Private Wealth LLC now owns 169,855 shares of the company’s stock valued at $4,255,000 after buying an additional 23,973 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd acquired a new stake in shares of Danimer Scientific in the second quarter valued at about $1,517,000. BHF RG Capital Inc. acquired a new stake in shares of Danimer Scientific in the second quarter valued at about $516,000. Advisor Group Holdings Inc. raised its position in shares of Danimer Scientific by 26.4% in the second quarter. Advisor Group Holdings Inc. now owns 23,933 shares of the company’s stock valued at $599,000 after buying an additional 4,998 shares during the last quarter. Finally, Advisory Services Network LLC grew its position in shares of Danimer Scientific by 323.1% in the first quarter. Advisory Services Network LLC now owns 8,461 shares of the company’s stock valued at $319,000 after purchasing an additional 6,461 shares in the last quarter. Institutional investors and hedge funds own 46.71% of the company’s stock.

DNMR has been the subject of a number of analyst reports. Zacks Investment Research upgraded Danimer Scientific from a “sell” rating to a “hold” rating in a research report on Thursday, September 23rd. Cowen started coverage on shares of Danimer Scientific in a research report on Thursday, September 23rd. They set an “outperform” rating and a $21.00 price target on the stock.

DNMR stock opened at $14.81 on Wednesday. The firm has a market cap of $1.45 billion, a PE ratio of -34.44 and a beta of -0.19. The company has a debt-to-equity ratio of 0.06, a quick ratio of 14.98 and a current ratio of 15.59. The firm’s 50 day moving average price is $16.70 and its 200-day moving average price is $20.97. Danimer Scientific, Inc. has a one year low of $10.50 and a one year high of $66.30.

Danimer Scientific (NYSE:DNMR) last released its quarterly earnings results on Monday, August 16th. The company reported ($0.07) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.03). The firm had revenue of $14.47 million for the quarter. Equities research analysts predict that Danimer Scientific, Inc. will post -0.51 EPS for the current fiscal year.

In other news, CMO Scott Tuten sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, September 17th. The shares were sold at an average price of $16.56, for a total value of $165,600.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders sold a total of 30,000 shares of company stock worth $452,100 over the last three months.

Danimer Scientific Profile

Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petrochemical-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including water bottles, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

Recommended Story: How do candlesticks reflect price movement?

Institutional Ownership by Quarter for Danimer Scientific (NYSE:DNMR)

Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.